131 related articles for article (PubMed ID: 24979113)
21. Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapy.
Sampériz G; Guerrero D; López M; Valera JL; Iglesias A; Ríos A; Campins A; Sala E; Murillas J; Togores B; Palmer J; Rodriguez M; Soriano JB; Sauleda J; Riera M; Agusti A
HIV Med; 2014 Jul; 15(6):321-9. PubMed ID: 24314004
[TBL] [Abstract][Full Text] [Related]
22. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
[TBL] [Abstract][Full Text] [Related]
23. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
[TBL] [Abstract][Full Text] [Related]
24. Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study.
Sabin CA; Hill T; Lampe F; Matthias R; Bhagani S; Gilson R; Youle MS; Johnson MA; Fisher M; Scullard G; Easterbrook P; Gazzard B; Phillips AN;
BMJ; 2005 Mar; 330(7493):695. PubMed ID: 15749728
[TBL] [Abstract][Full Text] [Related]
25. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
[TBL] [Abstract][Full Text] [Related]
26. A decision tree to help determine the best timing and antiretroviral strategy in HIV-infected patients.
Piroth L; Fournel I; Mahy S; Yazdanpanah Y; Rey D; Rabaud C; Faller JP; Hoen B; Fardeheb M; Quantin C; Chavanet P; Binquet C;
Epidemiol Infect; 2011 Dec; 139(12):1835-44. PubMed ID: 21232172
[TBL] [Abstract][Full Text] [Related]
27. Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination.
López-Palomo C; Martín-Zamorano M; Benítez E; Fernández-Gutiérrez C; Guerrero F; Rodríguez-Iglesias M; Girón-González JA
J Med Virol; 2004 Apr; 72(4):517-24. PubMed ID: 14981752
[TBL] [Abstract][Full Text] [Related]
28. Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents.
Briz V; León-Leal JA; Palladino C; Moreno-Perez D; de Ory SJ; De José MI; González-Tomé MI; Martín CG; Pocheville I; Ramos JT; Leal M; Muñoz-Fernández MÁ
Pediatr Infect Dis J; 2012 Mar; 31(3):273-7. PubMed ID: 22330165
[TBL] [Abstract][Full Text] [Related]
29. [Incidence of strokes in HIV-positive patients treated with long term antiretroviral treatment].
Mapoure YN; Nkongni IN; Luma HN; Ngahane BH; Barla E; Ngwane S; Mouelle AS; Njamnshi AK
Pan Afr Med J; 2016; 24():45. PubMed ID: 27642386
[TBL] [Abstract][Full Text] [Related]
30. HIV infection and incidence of ischemic stroke.
Marcus JL; Leyden WA; Chao CR; Chow FC; Horberg MA; Hurley LB; Klein DB; Quesenberry CP; Towner WJ; Silverberg MJ
AIDS; 2014 Aug; 28(13):1911-9. PubMed ID: 24937309
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program.
Puthanakit T; Oberdorfer A; Akarathum N; Kanjanavanit S; Wannarit P; Sirisanthana T; Sirisanthana V
Clin Infect Dis; 2005 Jul; 41(1):100-7. PubMed ID: 15937769
[TBL] [Abstract][Full Text] [Related]
32. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
[TBL] [Abstract][Full Text] [Related]
33. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
[TBL] [Abstract][Full Text] [Related]
34. Risk of first-line antiretroviral therapy failure in HIV-infected Thai children and adolescents.
Bunupuradah T; Sricharoenchai S; Hansudewechakul R; Klinbuayaem V; Teeraananchai S; Wittawatmongkol O; Akarathum N; Prasithsirikul W; Ananworanich J;
Pediatr Infect Dis J; 2015 Mar; 34(3):e58-62. PubMed ID: 25478649
[TBL] [Abstract][Full Text] [Related]
35. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
36. Clinical and immunologic outcomes of HAART-treated HIV-infected women in resource constrain settings: the Belgrade Study.
Dragović G; Salemović D; Ranin J; Nikolić J; Kušić J; Jevtović D
Women Health; 2014; 54(1):35-47. PubMed ID: 24555810
[TBL] [Abstract][Full Text] [Related]
37. Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infection.
Chow FC; Bacchetti P; Kim AS; Price RW; Hsue PY
AIDS; 2014 Nov; 28(17):2573-7. PubMed ID: 25160935
[TBL] [Abstract][Full Text] [Related]
38. Coronary artery disease in HIV infected patients.
Escaut L; Monsuez JJ; Chironi G; Merad M; Teicher E; Smadja D; Simon A; Vittecoq D
Intensive Care Med; 2003 Jun; 29(6):969-973. PubMed ID: 12739013
[TBL] [Abstract][Full Text] [Related]
39. The Role of Human Immunodeficiency Virus-Associated Vasculopathy in the Etiology of Stroke.
Benjamin LA; Allain TJ; Mzinganjira H; Connor MD; Smith C; Lucas S; Joekes E; Kampondeni S; Chetcuti K; Turnbull I; Hopkins M; Kamiza S; Corbett EL; Heyderman RS; Solomon T
J Infect Dis; 2017 Sep; 216(5):545-553. PubMed ID: 28931222
[TBL] [Abstract][Full Text] [Related]
40. Risk of intracerebral hemorrhage in HIV/AIDS: a systematic review and meta-analysis.
Behrouz R; Topel CH; Seifi A; Birnbaum LA; Brey RL; Misra V; Di Napoli M
J Neurovirol; 2016 Oct; 22(5):634-640. PubMed ID: 27044037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
